Nanjing Immunophage Biotech Co., Ltd

This early-stage study tested a new oral drug called IPG7236 in 63 healthy adults to see if it was safe and how the body processes it. The study was terminated before any results could be gathered. Because it only involved healthy volunteers, it does not provide information on wh…